Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs.

Source:http://linkedlifedata.com/resource/pubmed/id/20223500

Download in:

View as

General Info

PMID
20223500